Calmette-Guerin bacillus disseminated infection after intravesical instillation
Borré, S.; Brustia, D.; Rosa, F.; Brondolo, R.; Rizzo, G.; Garavelli, P.L.
Recenti Progressi in Medicina 93(4): 247-248
2002
ISSN/ISBN: 0034-1193 PMID: 11989131 Document Number: 541807
Local immunotherapy with bacillus Calmette-Guerin (BCG) is an effective and frequently used treatment for superficial bladder cancer. Serious side effects are infrequent but can affect every organ system. We describe a 53 year- old man with a disseminated bacillus Calmette-Guerin (BCG) infection after intravescical instillation for bladder carcinoma. Recent literature is reviewed for this rare complication.
Document emailed within 1 workday
Related Documents
Nishino, Y.; Yasuda, M.; Yokoi, S.; Ehara, H.; Yamamoto, N.; Takahashi, Y.; Ishihara, S.; Deguchi, T.; Kawada, Y.; Takeda, A.; Sakai, S.; Takeuchi, T.; Taniguchi, M.; Minoshima, K.; Hamamoto, Y.; Kanimoto, Y.; Nakano, M.; Fujihiro, S.; Nezasa, S.; Matsuda, T.; Nagatani, Y.; Maeda, S.; Tamaki, M.; Saito, A.; Komeda, H. 1999: Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(12): 1869-1873Shapiro, A.; Ratliff, T.L.; Oakley, D.M.; Catalona, W.J. 1983: Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity Cancer Research 43(4): 1611-1615
Kuramoto, T.; Nishikawa, T.; Nanpou, Y. 2018: A Case Report of Granulomatous Renal Masses Following Intravesical Instillation of Bacillus Calmette-Guérin Therapy Hinyokika Kiyo. Acta Urologica Japonica 64(5): 225-230
Lee, P.P. 2015: Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations Annals of the Academy of Medicine Singapore 44(8): 297-301
De Saint Martin, L.; Boiron, C.; Poveda, J.D.; Herreman, G. 1993: Generalized BCG infection after intravesical instillations of Calmette-Guerin bacillus Presse Medicale 22(29): 1352-1356
Muranaka, T.; Kunishima, Y.; Shigyo, M.; Kato, R.; Masumori, N.; Ito, N.; Tsukamoto, T.; Takagi, Y.; Seki, M.; Toida, I. 2007: Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report Hinyokika Kiyo. Acta Urologica Japonica 53(8): 581-584
Debruyne, F.M.; Witjes, J.A.; vd Meijden, A.P. 1990: Intravesical bacillus Calmette-Guérin (BCG) in superficial bladder tumors. An overview Archivos Espanoles de Urologia 43(Suppl): 133-138
Milas, L.; Maillefert, J.F.; Michel, F.; Piroth, C.; Wautot, A.; Tavernier, C. 1999: Refractory arthropathy after intravesical bacillus Calmette-Guérin therapy. Usefulness of isoniazide Revue du Rhumatisme 66(2): 106-108
Mitropoulos, D.; Deliconstantinos, G.; Zervas, A.; Giannopoulos, A.; Kyriakou, G.; Dimopoulos, C. 2000: Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations In Vivo 14(6): 721-724
De Boer, E.C.; De Jong, W.H.; Steerenberg, P.A.; Van der Meijden, A.P.; Aarden, L.A.; Debruyne, F.M.; Ruitenberg, E.J. 1991: Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin In Vivo 5(6): 671-677
Jurincic-Winkler, C.; Metz, K.A.; Beuth, J.; Sippel, J.; Klippel, K.F. 1995: Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder Anticancer Research 15(6b): 2771-2776
Ao, T.; Endo, T.; Shiokawa, H.; Shimura, S.; Adachi, K.; Koshiba, K. 1993: Kidney-conservative surgery followed by bacillus Calmette-Guerin instillation therapy for transitional cell carcinoma of solitary renal pelvis: a case report Hinyokika Kiyo. Acta Urologica Japonica 39(5): 463-465
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Pedrazzini, T.; Hug, K.; Louis, J.A. 1987: Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo Journal of Immunology 139(6): 2032-2037
Goupille, P.; Valat, J.P. 1996: Arthritis after bacillus Calmette-Guérin therapy Journal of Rheumatology 23(8): 1481-1482
Cerdá de Palou, E.; de Santy, H.P.R.M. 2003: Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG) Nederlands Tijdschrift Voor Geneeskunde 147(12): 569-572
Mitsogiannis, I.C.; Psaroudaki, Z.; Perrea, D.; Paniara, O.; Melekos, M.D.; Zervas, A.; Mitropoulos, D. 2006: In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG) Anticancer Research 26(6b): 4569-4573
Vázquez-Lavista, L.G.; Flores-Balcázar, C.H.é; Llorente, L. 2007: The bacillus Calmette-Guérin as immunomodulator in bladder cancer Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 59(2): 146-152
Brosman, S.A. 1992: Bacillus Calmette-Guérin immunotherapy. Techniques and results Urologic Clinics of North America 19(3): 557-564
Nesher, G. 1999: Bacillus Calmette-Guérin induced reactive arthritis Journal of Rheumatology 26(7): 1638